Where does SamanTree Medical SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), SamanTree Medical SA ranks #20,359 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does SamanTree Medical SA hold?

SamanTree Medical SA holds 14 US utility patents granted between 2018 and 2025, spanning 5 technology areas.

What is SamanTree Medical SA's Innovation Score?

SamanTree Medical SA has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does SamanTree Medical SA focus on?

SamanTree Medical SA's top technology area is G02B (Optical Elements, Systems OR Apparatus) with 14 patents, ranking #859 of 4,891 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is SamanTree Medical SA's patent grant rate increasing or decreasing?

SamanTree Medical SA's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for SamanTree Medical SA's patents?

SamanTree Medical SA's patents average 24.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the SamanTree Medical SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

SamanTree Medical SA

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02B (Optical Elements, Systems OR Apparatus).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Samantree ranks #20,359 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#20,359
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 24.5
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20359 · Foreign Corporation #20,359 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,359/49,997
PHOTO-FINISH SafeWorks
CPC-NARROW G02B · 5 areas
INNOV-PAR 42.0/100
CLAIMS-DENSE 24.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: SafeWorks, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Samantree’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (22%) Velocity 10.0 pts (24%) Breadth 7.9 pts (19%) Claim depth 14.7 pts (35%)

Qualcomm Incorporated · highest

85
SamanTree Medical · this assignee

42
3D Lighting… · lowest

7

What this shows Samantree's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Samantree?

Each dot is one of Samantree’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Samantree’s own 24.5 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Samantree vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Samantree's grants concentrate

SamanTree Medical SA is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under G02B (Optical Elements, Systems OR Apparatus). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2022. By volume, Samantree sits between SafeWorks, LLC and Scambia Holdings Cyprus Limited.

Samantree's three-year grant acceleration

SamanTree Medical SA shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Safeworks

14
Safran Passenger…

14
Saguna Networks

14
Saltel Industries

14
Sami-sabinsa Group

14
Samsung E&A

14
Saurer Intelligen…

14
Scambia Holdings…

14
Samantree Medical ◀

14

What this shows SamanTree holds 14 patents at rank #20,417, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near SamanTree

By rank, the assignees closest to #20,417 in granted patent volume.

Leaders in G02B (Optical Elements)

Other assignees with the most granted patents in SamanTree's primary technology class.

Samantree's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

SamanTree Medical SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	14.3%
2020	2	14.3%
2021	2	14.3%
2022	1	7.1%
2023	4	28.6%
2024	1	7.1%
2025partial year	2	14.3%

Which technologies does SamanTree Medical SA patent most?

G02B - Optical Elements, Systems OR Apparatus 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

A61B - DIAGNOSIS; SURGERY; Identification 6

H04N - Pictorial Communication, e.g. Television 4

G06T - Image Data Processing OR Generation, IN General 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

SamanTree Medical SA's patent record in context - here's where to go next.

SamanTree Medical SA's lead technology class is G02B (Optical Elements, Systems OR Apparatus), 100% of its portfolio - see every assignee active in that class. Explore G02B
Ranked #20,359 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare SamanTree Medical SA against SafeWorks, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.